ARTHRITIS BEATEN TODAY-CMO: THE IDEAL PROGRAM, CMO AS A PREVENTIVE, AND RECENT DEVELOPMENTS-DL-PHENYLALANINE (DLPA)

DLPA (DL-phenylalanine) is a very interesting substance that reduces pain quickly and effectively. It can help patients promptly gain a satisfying level of comfort while waiting for the long-lasting benefits of CMO to take effect. In the body endorphins are the natural substances produced to control the transmission of pain signals. Although they are non-narcotic, endorphins can be thought of as a sort of natural morphine.

DLPA prevents the normal hasty destruction of endorphins and thus inhibits the transmission of pain signals. It works by inhibiting the enzymes that break down endorphins, which results in extending their beneficial effects for a much longer time. In some people, DLPA sometimes acts as a mood enhancer as well.

L-phenylalanine and D-phenylalanine are natural amino acid substances commonly found in many protein foods. DL-phenylalanine is a combination of the two. Most people enjoy very prompt pain relief with DLPA and experience no negative side effects. It is safe and effective, gentle on the stomach, and not habit-forming. And it does not contribute through joint cartilage deterioration as do aspirin and other NSAIDS.

However take note that although not common, some people experience headaches or nausea from taking DLPA. People with high blood pressure, women who are pregnant or lactating, persons with psychoses, those suffering from malignant melanoma, those with phenylketonuria, or those with any sensitivity to phenylalanine should consult their physician before taking DLPA containing products. Taking DLPA with MAO or tricyclic antidepressants can lead to dangerously high blood pressure.

*96\142\2*

Share and Enjoy:
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • LinkedIn
  • Reddit
  • StumbleUpon
  • Twitter
  • Yahoo! Bookmarks

Related Posts:

This entry was posted on Tuesday, April 28th, 2009 at 11:20 am and is filed under Arthritis. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.